Results 161 to 170 of about 216,936 (304)

Harnessing noncanonical crRNA for highly efficient genome editing

open access: yesNature Communications
The CRISPR-Cas12a system is more advantageous than the widely used CRISPR-Cas9 system in terms of specificity and multiplexibility. However, its on-target editing efficiency is typically much lower than that of the CRISPR-Cas9 system.
Guanhua Xun   +5 more
doaj   +1 more source

Cuproptosis and Mitophagy Mediated by the THUMPD1/IGF2R‐Dependent Suppression of AKT and Activation of AMPK Signaling Suppress Lung Adenocarcinoma Progression

open access: yesAdvanced Science, EarlyView.
THUMPD1 drives a tumor‐suppressive signaling cascade in lung adenocarcinoma by promoting IGF2R expression. IGF2R associates with PPP2R1A to suppress AKT and activate AMPK, leading to SLC31A1 upregulation and copper accumulation. Elevated copper disrupts mitochondrial metabolism and induces excessive mitophagy, thereby restraining tumor growth and ...
Kai Wu   +10 more
wiley   +1 more source

Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing

open access: yes
Misganaw Asmamaw Mengstie,1 Muluken Teshome Azezew,2 Tadesse Asmamaw Dejenie,3 Assefa Agegnehu Teshome,4 Fitalew Tadele Admasu,1 Awgichew Behaile Teklemariam,1 Anemut Tilahun Mulu,1 Melaku Mekonnen Agidew,1 Dagnew Getnet Adugna,5 Habtamu Geremew,6 ...
Tadele Admasu F   +10 more
core  

UCHL3 Regulates Subgenomic Flaviviral RNA Condensates to Promote Virus Propagation

open access: yesAdvanced Science, EarlyView.
ABSTRACT Flavivirus subgenomic RNAs (sfRNAs) antagonise antiviral defences, yet how sfRNAs are organized and maintained in cells remains poorly understood. Here we identify ubiquitin C‐terminal hydrolase L3 (UCHL3) as a post‐translational regulator of flavivirus sfRNA stability and function.
Oscar Trejo‐Cerro   +7 more
wiley   +1 more source

Applications of CRISPR/Cas9 technology for tissue-specific genes inactivation in zebrafish embryos: a review of the methodology.

open access: yes
reservedLo sviluppo della tecnologia CRISPR/Cas9 per l’editing del genoma da parte di Charpentier e Doudna ha rivoluzionato il modo di fare ricerca. Questa tecnica, che ha valso loro il premio Nobel per la chimica nel 2020, si basa sull’utilizzo di una ...
MARCON, ELISA
core  

CRISPR-Cas9 knockout of CLU does not affect WPB number or size.

open access: yes
A CLUKO HUVEC cell line generated via CRISPR-Cas9 was analyzed for WPB number and WPB size. Representative immunofluorescent images showing DAPI (blue) and VWF staining (green) (5A) demonstrates appropriate cellular confluence and the expected shape of ...
Allaura A. Cox (17980027)   +2 more
core   +1 more source

Targeting Supramolecular Active Complexes of Nav1.7/Nav1.8 to Relieve Chronic Neuropathic Pain

open access: yesAdvanced Science, EarlyView.
In mice and patients with severe chronic neuropathic pain (NP), Nav1.7, Nav1.8, TrkB, and five cytoskeletal proteins form supramolecular active complexes (SMACs) with polygonal lattice structures as noxious signal amplifiers in dorsal root ganglion (DRG) neurons.
Liting Sun   +27 more
wiley   +1 more source

Strategies and Applications of Genomic Editing in Plants with CRISPR/Cas9

open access: yes
CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9) has revolutionized the field of genome editing, providing a powerful and versatile tool for precise modification of genetic material.
Ghorai, Mimosa   +6 more
core   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

open access: yesAdvanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy